002166 莱茵生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.3404.5585.2122.6637.246
总资产报酬率 ROA (%)0.8092.7523.3801.8174.634
投入资产回报率 ROIC (%)0.9613.3304.0332.1435.607

边际利润分析
销售毛利率 (%)23.71725.75129.32524.41530.799
营业利润率 (%)11.55010.02912.0467.92018.111
息税前利润/营业总收入 (%)14.60711.96513.4779.42417.576
净利润/营业总收入 (%)9.5427.4809.4356.58313.442

收益指标分析
经营活动净收益/利润总额(%)87.60592.142103.94075.37894.044
价值变动净收益/利润总额(%)-0.4654.4084.42843.12016.608
营业外收支净额/利润总额(%)-0.030-2.126-2.690-1.683-6.442

偿债能力分析
流动比率 (X)1.7651.5971.7042.0322.513
速动比率 (X)1.0020.8930.9251.2221.635
资产负债率 (%)36.17239.80036.22030.72330.126
带息债务/全部投入资本 (%)23.87724.18120.77515.72613.996
股东权益/带息债务 (%)301.396295.177360.235509.482577.684
股东权益/负债合计 (%)171.941147.351171.853220.366228.331
利息保障倍数 (X)4.7725.5787.7185.76331.330

营运能力分析
应收账款周转天数 (天)238.654198.195148.472106.84276.234
存货周转天数 (天)331.956299.095312.736302.341298.241